Scientists create detailed map of lymphoma to predict treatment success
NCT ID NCT04696692
Summary
This study aims to create a detailed map of immune and cancer cells in patients with diffuse large B-cell lymphoma. Researchers will follow 60 patients receiving standard R-CHOP treatment for two years, analyzing blood and tumor samples to identify biomarkers that could predict treatment response and disease progression. The goal is to better understand how lymphoma evolves during treatment to help guide future care decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Universitaire du Cancer Toulouse - Oncopole
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.